<?xml version='1.0' encoding='utf-8'?>
<document id="16867169"><sentence text="Inhibitory effects of cytostatically active 6-aminobenzo[c]phenanthridines on cytochrome P450 enzymes in human hepatic microsomes."><entity charOffset="44-74" id="DDI-PubMed.16867169.s1.e0" text="6-aminobenzo[c]phenanthridines" /></sentence><sentence text="Besides assays for the evaluation of efficacy new drug candidates have to undergo extensive testings for enhancement of pharmaceutical drug safety and optimization of application" /><sentence text=" The objective of the present work was to investigate the pharmacokinetic drug drug interaction potential for the cytostatically active 6-aminobenzo[c]phenanthridines BP-11 (6-amino-11,12-dihydro-11-(4-hydroxy-3,5-dimethoxyphenyl)benzo[c]phenanthridine) and BP-D7 (6-amino-11-(3,4,5-trimethoxyphenyl)benzo[c]phenanthridine) in vitro through incubation with human hepatic microsomes and marker substrates"><entity charOffset="136-252" id="DDI-PubMed.16867169.s3.e0" text="6-aminobenzo[c]phenanthridines BP-11 (6-amino-11,12-dihydro-11-(4-hydroxy-3,5-dimethoxyphenyl)benzo[c]phenanthridine" /><entity charOffset="258-322" id="DDI-PubMed.16867169.s3.e1" text="BP-D7 (6-amino-11-(3,4,5-trimethoxyphenyl)benzo[c]phenanthridine" /><pair ddi="false" e1="DDI-PubMed.16867169.s3.e0" e2="DDI-PubMed.16867169.s3.e0" /><pair ddi="false" e1="DDI-PubMed.16867169.s3.e0" e2="DDI-PubMed.16867169.s3.e1" /></sentence><sentence text=" For these studies the cytochrome P-450 isoenzymes and corresponding marker substrates recommended by the EMEA (The European Agency for the Evaluation of Medicinal Products) were chosen" /><sentence text=" In detail these selective substrates were caffeine (CYP1A2), coumarin (CYP2A6), tolbutamide (CYP2C9), S-(+)-mephenytoin (CYP2C19), dextromethorphane (CYP2D6), chlorzoxazone (CYP2E1) and testosterone (CYP3A4)"><entity charOffset="43-51" id="DDI-PubMed.16867169.s5.e0" text="caffeine" /><entity charOffset="62-70" id="DDI-PubMed.16867169.s5.e1" text="coumarin" /><entity charOffset="81-92" id="DDI-PubMed.16867169.s5.e2" text="tolbutamide" /><entity charOffset="94-100" id="DDI-PubMed.16867169.s5.e3" text="CYP2C9" /><entity charOffset="103-120" id="DDI-PubMed.16867169.s5.e4" text="S-(+)-mephenytoin" /><entity charOffset="122-129" id="DDI-PubMed.16867169.s5.e5" text="CYP2C19" /><entity charOffset="132-149" id="DDI-PubMed.16867169.s5.e6" text="dextromethorphane" /><entity charOffset="151-157" id="DDI-PubMed.16867169.s5.e7" text="CYP2D6" /><entity charOffset="160-173" id="DDI-PubMed.16867169.s5.e8" text="chlorzoxazone" /><entity charOffset="175-181" id="DDI-PubMed.16867169.s5.e9" text="CYP2E1" /><entity charOffset="187-199" id="DDI-PubMed.16867169.s5.e10" text="testosterone" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e0" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e1" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e2" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e4" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e5" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e6" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e7" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e8" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e0" e2="DDI-PubMed.16867169.s5.e10" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e1" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e2" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e4" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e5" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e6" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e7" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e8" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e1" e2="DDI-PubMed.16867169.s5.e10" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e2" e2="DDI-PubMed.16867169.s5.e2" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e2" e2="DDI-PubMed.16867169.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e2" e2="DDI-PubMed.16867169.s5.e4" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e2" e2="DDI-PubMed.16867169.s5.e5" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e2" e2="DDI-PubMed.16867169.s5.e6" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e2" e2="DDI-PubMed.16867169.s5.e7" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e2" e2="DDI-PubMed.16867169.s5.e8" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e2" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e2" e2="DDI-PubMed.16867169.s5.e10" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e3" e2="DDI-PubMed.16867169.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e3" e2="DDI-PubMed.16867169.s5.e4" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e3" e2="DDI-PubMed.16867169.s5.e5" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e3" e2="DDI-PubMed.16867169.s5.e6" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e3" e2="DDI-PubMed.16867169.s5.e7" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e3" e2="DDI-PubMed.16867169.s5.e8" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e3" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e3" e2="DDI-PubMed.16867169.s5.e10" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e4" e2="DDI-PubMed.16867169.s5.e4" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e4" e2="DDI-PubMed.16867169.s5.e5" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e4" e2="DDI-PubMed.16867169.s5.e6" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e4" e2="DDI-PubMed.16867169.s5.e7" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e4" e2="DDI-PubMed.16867169.s5.e8" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e4" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e4" e2="DDI-PubMed.16867169.s5.e10" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e5" e2="DDI-PubMed.16867169.s5.e5" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e5" e2="DDI-PubMed.16867169.s5.e6" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e5" e2="DDI-PubMed.16867169.s5.e7" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e5" e2="DDI-PubMed.16867169.s5.e8" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e5" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e5" e2="DDI-PubMed.16867169.s5.e10" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e6" e2="DDI-PubMed.16867169.s5.e6" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e6" e2="DDI-PubMed.16867169.s5.e7" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e6" e2="DDI-PubMed.16867169.s5.e8" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e6" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e6" e2="DDI-PubMed.16867169.s5.e10" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e7" e2="DDI-PubMed.16867169.s5.e7" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e7" e2="DDI-PubMed.16867169.s5.e8" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e7" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e7" e2="DDI-PubMed.16867169.s5.e10" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e8" e2="DDI-PubMed.16867169.s5.e8" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e8" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e8" e2="DDI-PubMed.16867169.s5.e10" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e9" e2="DDI-PubMed.16867169.s5.e9" /><pair ddi="false" e1="DDI-PubMed.16867169.s5.e9" e2="DDI-PubMed.16867169.s5.e10" /></sentence><sentence text=" Incubations with each substrate were carried out without a possible inhibitor and in the presence of a benzo[c]phenanthridine or a selective inhibitor at varying concentrations"><entity charOffset="104-126" id="DDI-PubMed.16867169.s6.e0" text="benzo[c]phenanthridine" /></sentence><sentence text=" Marker activities were determined by HPLC (high performance liquid chromatography)" /><sentence text=" For the isoenzymes showing more than 50% inhibition by the addition of 20 microM BP-11 or BP-D7 additional concentrations of substrate and inhibitor were tested for a characterization of the inhibition" /><sentence text=" The studies showed a moderate risk for BP-11 for interactions with the cytochrome P-450 isoenzymes CYP1A2, CYP2C9, CYP2D6 and CYP3A4" /><sentence text=" BP-D7, the compound with the highest cytotstatic efficacy, showed only a moderate risk for interactions with drugs, also metabolized by CYP3A4" /><sentence text="" /></document>